The orphan nuclear receptor SF-1 (steroidogenic factor 1) is highly expressed in the pituitary, gonad and adrenal glands and plays key roles at all levels of the hypothalamic-pituitarysteroidogenic tissue axis. In the present study, we show that PGC-1α [PPARγ (peroxisome-proliferator-activated receptor γ ) co-activator 1α] interacts with and co-activates SF-1 to induce LHβ (luteinizing hormone β) and αGSU (α-glycoprotein subunit) gene expression, subsequently leading to the increased secretion of LH in pituitary gonadotrope-derived αT3-1 cells. PGC-1α co-activation of LHβ expression requires an SF-1-binding element [GSE (gonadotrope-specific element)] mapped to the promoter region of LHβ. Mammalian two-hybrid and co-immunoprecipitation assays, as well as GST (glutathione transferase) pull-down experiments demonstrated that PGC-1α interacts with SF-1 in vivo and in vitro. Additionally, PGC-1α stimulates the expression of Cyp11b2 (aldosterone synthase gene), Cyp11b1 (steroid 11β-hydroxylase gene) and P450scc (cholesterol side-chain cleavage enzyme), and the synthesis of aldosterone in adrenal-cortex-derived Y-1 cells. Chromatin immunoprecipitation assays confirmed that endogenous PGC-1α co-localizes with SF-1 in the LHβ and Cyp11b2 promoter region. Knockdown of endogenous SF-1 by siRNA (small interfering RNA) abolished the PGC-1α induction of LHβ and Cyp11b2 gene expression in αT3-1 and Y-1 cells respectively. Finally, we demonstrated that PGC-1α induces SF-1 gene expression in both αT3-1 and Y-1 cells. Taken together, our findings reveal the potential role of PGC-1α and suggest that it may play important roles in steroidogenesis, gonad development and sex differentiation through SF-1.
INTRODUCTION
PGC-1α [PPARγ (peroxisome-proliferator-activated receptor γ ) co-activator 1α] is a member of a family of transcription coactivators which play central roles in regulating cellular energy metabolism. PGC-1α is highly induced in the liver and heart during fasting, in brown adipose tissue after exposure to cold temperature and in skeletal muscle while exercising [1, 2] . Current evidence suggests that PGC-1α can interact directly with and coactivate several nuclear receptors including, but not limited to, all ERR (oestrogen-related receptor) [3, 4] and PPAR subtypes [5, 6] , FOXO1 (forkhead box O1) [7] and NRF-1 (nuclear respiratory factor 1) [8] . Generally, the interactions between PGC-1α and nuclear receptors involve an LXXLL motif located at the N-terminal amino acids 142-146 of PGC-1α and the C-terminal AF-2 domain of nuclear receptors. PGC-1α (Ppargc1a)-knockout mice exhibit multiple metabolic defects, such as obesity, neurodegeneration and cardiomyopathy [9, 10] . PGC-1α plays important roles in adaptive thermogenesis in brown adipose tissue, gluconeogenesis in the liver, mitochondrial biogenesis and respiration in muscle cells, and heart development [1, 11] .
SF-1 (steroidogenic factor 1; encoded by Nr5a1), a member of the nuclear hormone receptor superfamily, is highly expressed in steroidogenic tissues, including adrenal cortex and gonads, as well as non-steroidogenic tissues, such as pituitary gonadotropes and hypothalamus [12] . SF-1 plays key roles in several physiological processes, including steroid synthesis, adrenal and gonadal development, and sex differentiation [13] . In pituitary gonadotropes, SF-1 stimulates the expression of the genes encoding αGSU (α-glycoprotein subunit), LHβ (luteinizing hormone β) and FSHβ (follicle-stimulating hormone β), by which SF-1 influences the reproductive axis [12] . LH is a pituitary-derived glycoprotein hormone that belongs to a family of hormones that includes FSH, TSH (thyroid-stimulating hormone) and CG (chorionic gonadotropin) [14] . LH is encoded by two genes located on different chromosomes, so it is a heterodimeric glycoprotein, consisting of an αGSU common to all family members and a unique β-subunit that associates non-covalently [14] . Sequence analysis of LHβ gene promoters from a broad range of species reveals the presence of a consensus GSE (gonadotrope-specific element; TGACCTTGT). SF-1 binds this element, and overexpression of Nr5a1 (mouse SF-1 gene) in the murine gonadotrope-derived αT3-1 cell line activates bovine LHβ promoter activity [15, 16] . The expression of LHβ mRNA is markedly decreased in SF-1 (mouse gene symbol Nr5a1)
− / − mice [17] .
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cholesterol mobilization and steroid hormone biosynthesis in steroidogenic cells, including cytochrome P450 steroid hydroxylases, StAR (steroidogenic acute regulatory protein) and HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) synthase [12, 18] . ALD (aldosterone), the principal human mineralocorticoid, is produced in the zona glomerulosa of the adrenal gland. The final key steps in ALD synthesis are sequential 11-hydroxylation, 18-hydroxylation and 18-oxidation of the precursor steroid deoxycorticosterone in zona glomerulosa cells. A single enzyme, ALD synthase, carries out all of these steps and is encoded by the gene Cyp11b2 [19] . Human CYP11B2 transcription is stimulated by angiotensin II, potassium ions and cAMP signalling pathways using the SF-1 and CRE (cAMP-response element)-like cis-elements, which are located at positions − 71/ − 64 (TGACGTGA) and − 129/ − 114 (CTCCAGCCTTGACCTT) respectively [20] . SF-1-knockout mice exhibit adrenal and gonadal agenesis, male-to-female sex reversal of internal and external genitalia, impaired expression of pituitary gonadotropins and structural abnormalities of ventromedial hypothalamic nucleus [17, 21] . In addition, the structure of SF-1 has also been characterized to understand the molecular mechanism of transcriptional activity. The AF-2 transactivation domain is absolutely conserved in all SF-1 proteins from several species, including human, bovine, rat and mouse [13] . The proximal activation domain located at C-terminal residues 187-245 in SF-1 is required for its transcriptional activity and can physically interact with its co-activators, such as SRC-1 (steroid receptor co-activator-1) and TReP-132 (transcriptional regulating protein of 132 kDa) [22] [23] [24] .
A recent study revealed that PGC-1α can induce the expression of CYP11A1 and CYP17A1, which encode the key rate-limiting enzymes involved in the initial steps of steroidogenesis in hepatic cells [25] , suggesting that PGC-1α may function in a much broader aspect in endocrine, more than energy, metabolism. In the present study, we show that PGC-1α induced αGSU and LHβ gene expression in αT3-1 cells and the expression of several key enzymes involved in steroidogenesis, including Cyp11b2 and P450scc, in Y-1 cells. These results imply that PGC-1α may influence steroid synthesis, adrenal and gonadal development and sex differentiation by co-activating SF-1.
MATERIALS AND METHODS

Plasmids and adenoviruses
Full-length mouse SF-1 (GenBank ® accession number NM_139051) was obtained by PCR amplification of cDNA from mouse ovary and cloned into pCMV-HA (Clontech) with EcoRI/BglII restriction sites and pACT (Promega) with BamHI/XbaI sites respectively. The different truncated versions of SF-1 encoding amino acids 187-451, amino acids 187-462, amino acids 246-451 and amino acids 246-462 were all cloned into pCMV-HA (Clontech). Full-length mouse PGC-1α (GenBank ® accession number NM_008904) was subcloned into pBIND (Promega) from a construct expressing PGC-1α-Myc, which was a gift from Dr Teresa C. Leone (Center for Cardiovascular Research, Washington University School of Medicine, St. Louis, MO, U.S.A.). Full-length ERRα (GenBank ® accession number NM_004451) was cloned into pcDNA3.1 as described previously [26] . Full-length ERRγ (GenBank ® accession number NM_001438) was cloned into pCMV-HA with EcoRI/XhoI sites. The 5 -end of the mouse SF-1 gene extending from position − 1892 bp (relative to the transcription start site) to +147 was cloned into the pGL3-Basic (Promega) luciferase reporter plasmid with the SacI/SmaI sites. The mouse LHβ gene promoter (− 948 to +264 bp) was amplified using mouse genomic DNA and inserted into pGL3-Basic (− 948Luc). A series of 5 -deletion and corresponding mutation constructs of LHβ (− 948mut, − 160, − 160mut, − 100 to +264) were prepared by PCR using − 948Luc as a template. The plasmid pGEX-PGC-1α-180 expressing the GST (glutathione transferase)-fused N-terminal 180 amino acids of PGC-1α was a gift from Dr Bruce Spiegelman (Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, U.S.A.). The construct containing siRNA (small interfering RNA) against mouse SF-1 was generated by subcloning a double-stranded oligomer targeted to nucleotides 321-341 of mouse SF-1 mRNA (GenBank ® accession number NM_139051) [27] into the BbsI site of pBabe-Dual (from Dr Ye Zhang, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China) [28] . All constructs were confirmed by direct nucleotide sequencing, and the primers used for plasmid construction are shown in Supplementary Table  S1 at http://www.BiochemJ.org/bj/432/bj4320473add.htm. Ad-PGC-1α (adenovirus expressing PGC-1α) was constructed by cloning full-length PGC-1α into the pAd-Track vector at SalI and EcoRV sites. Recombination with pAdEasy-1 and propagation of adenovirus expressing PGC-1α in HEK (human embryonic kidney)-293A cells was performed as described previously [26] .
Cell culture, transfection and adenovirus infection
Murine adrenocortical Y-1 cells were obtained from A.T.C.C. and cultured in F-12 medium containing 15 % horse serum and 2.5 % FBS (fetal bovine serum), supplemented with 2 mM L-glutamine, 100 units/ml penicillin and 0.1 mg/ml streptomycin incubated at 37
• C with 5 % CO 2 . Murine gonadotrope-derived αT3-1 cells were maintained at 37
• C with 5 % CO 2 in DMEM (Dulbecco's modified Eagle's medium)/F-12 supplemented with 10 % FBS, 100 units/ml penicillin and 0.1 mg/ml streptomycin. HEK-293ET, HEK-293A and CV-1 cells were cultured in highglucose DMEM with 10 % FBS and antibiotics.
Generally, cells were plated 24 h or 48 h prior to transient transfection using Lipofectamine TM 2000 reagent (Invitrogen) according to the manufacturer's protocol. For adenoviral infection, Y-1 and αT3-1 cells were infected for 48 h at a multiplicity of infection sufficient to infect >95 % of cells.
Luciferase assays
All experiments were performed using the Dual-Luciferase Reporter Assay System (Promega) with an internal Renilla luciferase control plasmid to normalize transfection efficiencies. In general, αT3-1, 293ET and CV-1 cells were plated in 24-well plates. After 12-24 h, cells were transfected with 0.25 μg of firefly luciferase reporter constructs of serial 5 -deletions or singlebp mutation promoters, 10 ng of pRL-TK (thymidine kinase promoter-Renilla luciferase reporter plasmid) and expression plasmids (0.5 μg of PGC-1α; 0.25 μg of SF-1, ERRα and ERRγ ; or as specifically described). Cells were harvested 24-48 h after transfection. Reporter gene activity was calculated as activity over basal levels generated from transfection of the firefly luciferase reporter gene, pRL-TK and pcDNA3.1. The results represent the means + − S.D. of at least three independent experiments.
Mammalian two-hybrid assays
The CheckMate TM Mammalian Two-Hybrid System (Promega) was used according to the manufacturer's protocol. Briefly, 1 × 10 5 cells were plated in a 24-well plate. On the following day, 0.25 μg of the pACT (VP16) and pBIND (GAL4) fusion constructs and 0.25 μg of pG5luc were transfected. Cells were incubated for 24 h before harvesting, and luciferase activity was screened using the Dual-Luciferase Reporter Assay System. These experiments were performed in triplicate and repeated in three independent experiments.
ChIP (chromatin immunoprecipitation)
ChIP assays in mouse αT3-1 cells and Y-1 cells were performed as described previously [29] . Cells were cultured on 100-mm dishes and cross-linked with 1 % formaldehyde, lysed and subjected to chromatin shearing by sonication. Input samples were obtained at 1 % (v/v), followed by immunoprecipitation with specific antibody at 4
• C overnight. The antibodies used were anti-SF-1, anti-PGC-1α or, as a negative control, IgG antibody. Immune complexes were collected with 50 μl of Protein GSepharose TM 4 Fast Flow beads. PCR analysis was performed with input and immunoprecipitated DNA. The primers were designed to amplify the proximal region of the mouse SF-1 promoter containing GSE or the distal region without GSE as a negative control. The specific primers are shown in Supplementary Table S2 (at http://www.BiochemJ.org/bj/432/bj4320473add.htm).
RNA isolation and real-time PCR
The αT3-1, Y-1 and CV-1 cells were plated at a density of 60 % in 60-mm dishes and transfected and/or infected for 48 h. Total RNA was extracted using TRIzol ® reagent (Invitrogen) as specified by the manufacturer. RNA (4 μg) was reverse transcribed to cDNA using the Transcriptor High Fidelity cDNA Synthesis Sample kit (Roche), and specific transcripts were quantified by real-time PCR using an iQ5 Real-Time PCR Detection System (Bio-Rad). Quantitative real-time PCR was performed using TransStart Green qPCR SuperMix (TransGen Biotech). Primers used in the study are shown in Supplementary Table S3 (at http://www.BiochemJ.org/bj/432/bj4320473add.htm). Relative mRNA levels for the specific genes were normalized to β-actin mRNA levels.
Western blot analysis
Adenoviruses were infected into αT3-1 or Y-1 cells in 60-mm dishes. Cells were incubated for 48 h after infection and subsequently lysed in lysis buffer [50 mM Tris/HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA, 1 % Nonidet P40, 1 % SDS, 1 mM PMSF, 1 mM DTT (dithiothreitol) and protease inhibitors]. CV-1 cells were transfected with plasmids expressing PGC-1α and/or SF-1, or with pcDNA3.1 (negative control) for 48 h. Whole-cell proteins (60 μg) were used for Western blot analysis. and protease inhibitors] on ice for 1 h. The supernatants were incubated with the glutathione-Sepharose 4B beads carrying the GST or GST-fusion protein overnight at 4
• C. The beads were then washed four times for 10 min each with the lysis buffer before Western blot analysis with an anti-HA antibody (Sigma), as described above.
Co-immunoprecipitation assays
Plasmids expressing HA-tagged SF-1 and Myc-tagged PGC-1α were co-transfected into αT3-1 cells using Lipofectamine TM 2000. Total cell extracts were prepared with immunoprecipitation lysis buffer [10 mM Tris/HCl (pH 7.4), 250 mM NaCl, 1 % Nonidet P40, 1 mM EDTA, 1 mM PMSF and protease inhibitors] on ice for 2 h, followed by pre-clearing with Protein G-Sepharose TM 4 Fast Flow beads (GE Healthcare) at 4
• C for 2 h. Equal amounts of total cell extracts were incubated with an anti-HA or IgG antibody at 4
• C overnight prior to adding Protein G-Sepharose TM 4 Fast Flow beads at 4
• C for 4 h. Immunoprecipitates were washed five times with PBS supplemented with freshly prepared protease inhibitors. Immunocomplexes were resolved by SDS/PAGE and transferred on to PVDF membranes. Western blot analysis was performed using an anti-Myc antibody (Santa Cruz Biotechnology) as described above. 
ELISA
ELISAs were performed to determine mouse LH and ALD levels in the medium of αT3-1 and Y-1 cells respectively. Media were harvested 24 h after transfection, and LH and ALD were determined using the Mouse LH ELISA kit (Uscn) and Mouse ALD ELISA kit (Uscn) according to the manufacturer's protocol. The concentrations were calculated by adopting the absorption value into standard curves and normalizing to the amount of cells in each condition. Results are shown as the means + − S.D. and represent at least three independent experiments.
Statistical analysis
Results are means + − S.D. of at least three independent experiments. One-way ANOVA was applied to data followed by a Student's t test, and P < 0.05 was considered statistically significant.
RESULTS
PGC-1α induces LHβ and αGSU gene expression in αT3-1 cells
To date, few studies have been performed to define the roles of PGC-1α in endocrine organs, such as adrenal, gonads and pituitary. Since PGC-1α can co-activate a number of transcription factors to stimulate downstream target genes, we hypothesized that PGC-1α may affect the expression of some key genes in these tissues. To validate this hypothesis, αT3-1 cells derived from pituitary gonadotropes were used as a model system to examine the effect of PGC-1α on the expression of LHβ, FSHβ and αGSU. αT3-1 cells were infected with Ad-PGC-1α or GFP (green fluorescent protein) as a negative control ( Figure 1A ). Total RNA was extracted from these cells and quantified by real-time PCR. Indeed, overexpression of PGC-1α led to marked inductions of LHβ and αGSU, and a modest increase in FSHβ ( Figure 1B ). This result indicates that PGC-1α functions as an upstream activator of these genes in αT3-1 cells.
PGC-1α-dependent activation of LHβ transcription is mediated by SF-1
To determine whether PGC-1α-dependent induction of LHβ gene expression occurs at the transcriptional level, we performed promoter-reporter transfections in αT3-1 cells. The first construct (− 948Luc) contained the ∼1.2-kb promoter region of LHβ (from − 948 bp to +264 bp) governing the expression of luciferase. Co-transfection of − 948Luc with a PGC-1α-expressing vector resulted in a marked activation of the reporter gene (Figure 2A) . To map the cis-acting region conferring the PGC-1α-dependent activation of the luciferase reporter gene, we performed cotransfection experiments with reporter constructs harbouring serial deletions at the 5 -end of the LHβ promoter. Our results indicate that this activation still remained after truncation of the promoter region to begin at − 160 bp (Figure 2A) . To deduce the molecular mechanism, we searched for the sequence motif in the PGC-1α-responsive nucleotide region. A screen of 424 bp between − 160 bp and +264 bp revealed a clear GSE (TGACCTTGT), which is reported to be highly conserved in the LHβ promoter from different species and mediates SF-1 activation of the LHβ gene ( Figures 2B and 2C ) [30] [31] [32] . The fact that PGC-1α can interact directly with and co-activate a number of nuclear receptors prompted us to speculate about the participation of SF-1 in PGC-1α-induced activation of LHβ gene transcription. To test this potential interaction, mutational studies were performed. When GSE was mutated in a way that has been shown previously to inactivate this element [15] , we observed that the PGC-1α co-activation of the LHβ reporter gene was lost (Figures 2A and 2D) , suggesting that the GSE identified in the LHβ promoter is involved in PGC-1α action.
To further confirm the involvement of SF-1 in the PGC-1α co-activation of LHβ, a series of reporter gene transfection experiments was performed. In agreement with previous results [15, 16] , SF-1 activated the − 948Luc and − 160Luc reporter genes, which contained the wild-type SF-1-binding site (GSE), and co-transfection of SF-1 and PGC-1α led to a synergic effect on these two reporter gene constructs ( Figure 2D ). However, a further truncated promoter reporter gene (− 100Luc) was not activated by SF-1 in the absence or presence of PGC-1α. Moreover, mutations of the GSE in the LHβ promoter (− 948mutLuc and − 160mutLuc) abolished the responses to SF-1 and/or PGC-1α (Figures 2A and 2D ). Thus these results indicate that SF-1 and PGC-1α activate the mouse LHβ gene promoter via a GSE.
PGC-1α interacts with SF-1 in vivo
The results described above imply that PGC-1α-dependent activation of the LHβ promoter is mediated by GSE and presumably requires direct interaction with SF-1. To further demonstrate that the SF-1-binding site (GSE) may mediate the PGC-1α co-activation of the mouse LHβ promoter in vivo, ChIP assays were performed in αT3-1 cells. The immunoprecipitates were subjected to PCR using a pair of primers designed to amplify the proximal region of the mouse LHβ promoter (from − 243 bp to − 2 bp) containing the GSE. As shown in Figure 3(A) , the proximal region of the LHβ promoter could be amplified from precipitates obtained using anti-SF-1 or anti-PGC-1α antibodies; however, no signal was observed in the immunocomplex with IgG. As the negative control, the distal promoter region without GSE could not be amplified from any of the immunoprecipitates. Taken together, these results suggest that endogenous SF-1 and PGC-1α occupy the promoter site of mouse LHβ. Considering that PGC-1α cannot bind DNA directly, the association of PGC-1α with this promoter occurs via binding to SF-1.
To confirm the interaction between PGC-1α and SF-1 in intact cells, we first performed mammalian two-hybrid assays in αT3-1 cells. For this, full-length SF-1 was fused to the transactivation domain of VP16 in pACT (pACT-SF-1), and full-length PGC-1α was fused to the GAL4 DNA-binding domain in pBIND (pBIND-PGC-1α). The two vectors were co-expressed with the pG5luc reporter plasmid containing five GAL4-binding sites. The coexpression of both fusion proteins yielded an induction of promoter activity much stronger than that obtained by coexpressing pACT-SF-1 with pBIND or pBIND-PGC-1α with pACT ( Figure 3B ). This result indicates a direct interaction between PGC-1α and SF-1.
In addition, co-immunoprecipitation assays were performed to examine the interaction between PGC-1α and SF-1 in vivo. A plasmid encoding Myc-tagged PGC-1α was co-transfected into αT3-1 cells with HA-tagged SF-1. Potential protein complexes were immunoprecipitated using an anti-HA or IgG antibody and subjected to Western blot using an anti-Myc antibody ( Figure 3C ). PGC-1α was efficiently precipitated using an anti-HA antibody, or PGC-1α (Ad-PGC-1α), proteins were extracted, and Western blot analysis was performed using antibodies specific to PGC-1α and β-actin. (B) Y-1 cells were treated as described in (A), and total RNA was extracted 48 h after infection. The mRNA levels of Cyp11b1, Cyp11b2 and P450scc were determined by real-time PCR, normalized to β-actin and expressed relative to the GFP-expressing control cells. Values are the means + − S.D. of three independent experiments (*P < 0.05, compared with control Ad-GFP-infected cells). (C) ChIP assays were performed in Y-1 cells. Y-1 cells were cultured in 100-mm dishes, and cross-linked DNA fragments were immunoprecipitated with an anti-SF-1, anti-PGC-1α or IgG antibody (as a control). Cyp11b1, Cyp11b2 and P450scc promoter regions harbouring GSEs were amplified specifically by PCR. However, the distal regions without GSEs, used as negative controls, could not be amplified.
whereas it was not detectable with control IgG. These results clearly indicate that PGC-1α interacts with SF-1 in vivo.
Interaction between PGC-1α and SF-1 involves the N-terminal region of PGC-1α and two regions of SF-1
The activation domain of PGC-1α, containing the LXXLL motif (amino acids 142-146), is responsible for interaction with a number of hormone nuclear receptors [5, 6, 33, 34] . In addition, the AF-2 hexamer (LLIEML) at the C-terminus of SF-1, which is conserved in several nuclear receptors, and the proximal activation domain (amino acids 187-245) are required for the SF-1 transcriptional activity [22] . We hypothesized that these domains mediate the direct interaction between PGC-1α and SF-1. Thus GST pull-down assays were performed. First we obtained Figure 4A ). SF-1 was produced either as a full-length protein or as truncated versions ( Figure 4B ), and all of them were HA-tagged. As shown in Figure 4 (C) (right-hand panel), full-length SF-1 exhibited strong binding to GST-PGC-1α-(1-180), but no binding to GST (middle panel), suggesting that PGC-1α interacts with SF-1 through amino acids 1-180 of PGC-1α. Meanwhile, we observed that PGC-1α still bound to SF-1 with a deleted DNA-binding domain. However, a further deletion of the proximal activation domain or AF-2 domain of SF-1 essentially eliminated its interaction with PGC-1α. As a control, no binding was observed between various versions of SF-1 and GST alone. Our data suggest that PGC-1α interacts directly with SF-1 in vitro and that this interaction involves the N-terminal region of PGC-1α (amino acids 1-180) and at least two regions of SF-1, the proximal activation domain and the AF-2 domain.
PGC-1α induces genes involved in steroidogenesis in adrenal-cortex-derived Y-1 cells
Since SF-1 is also highly expressed in adrenal cortex and our results indicate that PGC-1α interacts directly with and co-activates SF-1 to induce LHβ gene expression, we next determined whether PGC-1α stimulates target genes of SF-1 in adrenal-cortex-derived cells. Y-1 cells were used as a model system and infected with Ad-PGC-1α or GFP as a negative control ( Figure 5A ). Total RNA was extracted from these cells and estimated by real-time PCR. As anticipated, we observed that overexpression of PGC-1α led to an increase in the expression of several SF-1 target genes, including Cyp11b2, Cyp11b1 and P450scc ( Figure 5B) . A previous study showed that there is a GSE from − 67 to − 55 bp in the P450scc promoter that is highly conserved among different species, including bovine, rat, mouse and humans [35] , and a proposed GSE from − 440 bp to − 219 bp in the Cyp11b2 promoter was also identified [20] . In addition, there is a putative SF-1-binding site in the Cyp11b1 promoter between − 265 and − 52 bp [20, 36] . A ChIP assay was performed in Y-1 cells, and we found that PGC-1α was recruited to the proximal regions of these genes containing GSEs in Y-1 cells ( Figure 5C ).
PGC-1α synergizes with SF-1 to promote the synthesis of LH and ALD
Since PGC-1α interacted with SF-1 and stimulated LHβ and Cyp11b2 gene transcription, we decided to determine whether these two factors could synergize to influence downstream target genes. αT3-1 and Y-1 cells were transfected with PGC-1α and/or SF-1 expression plasmids. Total RNA was extracted, and LHβ and Cyp11b2 were measured by real-time PCR. As shown in Figure 6 (A), overexpression of PGC-1α or SF-1 alone in αT3-1 cells led to a modest increase in LHβ gene expression; however, overexpression of PGC-1α and SF-1 dramatically induced LHβ. Additionally, we observed a similar effect of PGC-1α and SF-1 on Cyp11b2 gene expression in Y-1 cells ( Figure 6B ). These results indicate that PGC-1α and SF-1 have synergic effects on these target genes.
Our ELISA results show that overexpression of PGC-1α and SF-1 led to a markedly increased level of LH in the medium of αT3-1 cells, much more than that obtained by transfection of PGC-1α or SF-1 alone ( Figure 6C ). Additionally, overexpression of PGC-1α or SF-1 in Y-1 cells induced the synthesis of ALD, and co-transfection of these factors further increased the ALD level in the medium ( Figure 6D) .
To determine the role of SF-1 in the PGC-1α co-activation of LHβ and Cyp11b2, siRNA against SF-1 was employed to knockdown endogenous SF-1 gene expression in αT3-1 cells and Y-1 cells (Figures 7A and 7B) . Knockdown of SF-1 by siRNA abolished the PGC-1α induction of LHβ and Cyp11b2 gene expression ( Figures 7C and 7D) , which suggests that SF-1 mediates the PGC-1α action on target genes LHβ and Cyp11b2.
PGC-1α induces SF-1 gene expression
Several transcription factors, including NRF-1 and ERRα, coactivated by PGC-1α can also be induced by PGC-1α at the mRNA level [8, 37] . Next, to study whether PGC-1α can increase SF-1 gene expression, quantitative real-time PCR assays were performed in αT3-1 and Y-1 cells infected with Ad-PGC-1α or GFP as a control. We observed that the overexpression of PGC-1α powerfully stimulated SF-1 gene expression in both αT3-1 and Y-1 cells (Figures 8A and 8B) . Our Western blot results also confirmed that PGC-1α induced the expression of SF-1 at the protein level in these two cell lines (Figures 8C and  8D ). To determine whether PGC-1α-dependent induction of SF-1 gene expression occurs at the transcriptional level, we performed promoter-reporter transfections in 293ET cells. Overexpression of PGC-1α caused a modest activation of an SF-1 promoter luciferase gene ( Figure 8E ). Inspecting the sequence of the 5 -flanking region of mouse SF-1 (− 1892 to +1 bp), several potential transcription-factor-binding elements were identified, such as those recognized by HNF4 (hepatocyte nuclear factor 4), SOX9 [SRY (sex-determining region Y)-box 9], PPARs and ERRs. Thus we tested these candidate transcription factors mediating PGC-1α action on SF-1 transcription. As shown in Figure 8 (F), transfection of ERRγ increased SF-1 gene promoter activity (2.0 + − 0.7-fold), and overexpression of ERRα alone did not change the luciferase activity. However, co-transfection of PGC-1α and ERRα or ERRγ led to the dramatic activation of SF-1 promoter activity. Meanwhile, the other factors did not influence SF-1 promoter activity (results not shown). In addition, increasing amounts of PGC-1α expression plasmids were co-transfected into 293ET cells with ERRα, and a dose-dependent activation of the SF-1 promoter was observed ( Figure 8G ). These results indicate that PGC-1α can co-activate ERRα to activate SF-1 promoter activity.
These data allow us to propose a 'dual-regulation model' mechanism of PGC-1α action on the production of hormones, including LH and FSH, in pituitary-derived cells and steroidogenesis in adrenal-cortex-derived cells (Figure 9 ). In this model, PGC-1α co-activates ERRs or other factors to induce SF-1 gene expression; meanwhile, PGC-1α interacts directly with and co-activates SF-1 to stimulate SF-1 downstream target genes, 
DISCUSSION
To date, PGC-1α has been extensively studied in various tissues, including brown adipose tissue, skeletal muscle, heart, brain and liver. However, the physiological function of PGC-1α is less known in other tissues. We decided to determine its role in cells of endocrine tissues, such as adrenal, gonads and pituitary. Thus we first performed studies using αT3-1 cells derived from pituitary gonadotropes as a model system. We examined mRNA levels of several genes, including LHβ, FSHβ and αGSU, all of which encode secreted hormones affecting reproductive development and function. We observed that LHβ and αGSU were significantly induced by PGC-1α.
We speculated that PGC-1α may co-activate one or more transcription factors to activate LHβ and αGSU gene expression. Several transcription-factor-binding sites exist in the LHβ promoter, including Egr1 (early growth response protein 1), SF-1, Pitx1 (pituitary homeobox 1) and NF-Y (nuclear factor-Y) sites [38] . In addition, USF (upstream stimulatory factor), CREB (CRE-binding protein), GATA2 (GATA-binding protein 2), SF-1, LH-2 and Mst-1 (macrophage stimulating 1) can bind to and activate the αGSU promoter [14] . The mutation of the SF-1-binding element abolished PGC-1α-activating LHβ, suggesting that SF-1 mediates PGC-1α-dependent induction of LHβ gene expression. Furthermore, the synergy between PGC-1α and SF-1 was demonstrated in SF-1-deficient CV-1 cells (Supplementary Figure S1 at http://www.BiochemJ. org/bj/432/bj4320473add.htm).
The data in the present study provide substantial evidence that PGC-1α can interact directly with SF-1. First, overexpression of PGC-1α or SF-1 alone led to activation of the LHβ promoter, whereas co-transfection of PGC-1α and SF-1 caused a synergic effect. Secondly, mammalian two-hybrid assays indicated that activation of the pG5luc reporter gene by co-transfection of PGC-1α-BIND and SF-1-ACT was much stronger than PGC-1α-BIND or SF-1-ACT alone. Thirdly, co-immunoprecipitation assays indicated that PGC-1α interacts with SF-1 in vivo. Fourthly, GST pull-down assays revealed a direct interaction between PGC-1α and SF-1.
As a co-activator, PGC-1α is recruited to particular DNA sequences in gene promoters through direct interaction with transcription factors. Embedded in the N-terminal 200 amino acids of PGC-1α is an LXXLL sequence (amino acids 142-146), which is absolutely required for the ligand-dependent interaction with ER (oestrogen receptor) [34] , PPARα [6] , RXRα (retinoid X receptor α) [39] and GR (glucocorticoid receptor) [40] . Our results clearly demonstrate that PGC-1α binds intensively to SF-1 through the N-terminal region of PGC-1α containing this LXXLL motif (amino acids 1-180). GST pull-down assays confirmed that SF-1 interacts with PGC-1α through its C-terminus (amino acids 187-462). Deletion of the SF-1 proximal activation domain or AF-2 domain abolished this interaction, suggesting that both domains are required for the SF-1 interaction with PGC-1α.
Although a number of SF-1 target genes are induced by PGC-1α in Y-1 cells, we observed that several target genes are not influenced, including Cyp19a1 and Cyp21a1 (results not shown). A striking feature of co-activation by PGC-1α is that it is promoterselective.
The results of the present study clearly demonstrate that overexpression of PGC-1α and SF-1 leads to an increase in Cyp11b2 transcription and subsequently promotes the synthesis of ALD in Y-1 cells. A previous study showed that Cyp11b2 transcription is stimulated by angiotensin II, potassium ions and cAMP signalling pathways using the SF-1 and CRElike cis-elements [20] , so PGC-1α may induce Cyp11b2 gene expression through co-activating SF-1. In addition, recent studies suggest that ALD contributes to blood pressure homoeostasis [41] . Overproduction of ALD causes cardiovascular disease. Since PGC-1α co-activates SF-1 to stimulate ALD production in Y-1 cells, PGC-1α may be involved in cardiovascular pathophysiology.
PGC-1α interacts directly with ERRα [4] . Additionally, PGC-1α can induce ERRα gene expression [37, 42] . Similar phenomena occur with PGC-1α and NRF-1 [5, 8] . In the present study, we showed that PGC-1α not only interacts directly with SF-1, but also induces SF-1 gene expression in gonadotrope-derived αT3-1 cells and adrenocortical Y-1 cells. Previous reports have shown that SOX9 activates the SF-1 promoter [43] and PGC-1α can co-activate SOX9 to regulate chondrogenesis [44] , so we hypothesized that PGC-1α co-activates SOX9 to activate the SF-1 promoter; however, we did not observe this.
We did identify a potential ERR-binding element (− 227 to − 219 bp) in the mouse SF-1 promoter. Our data suggest that PGC-1α co-activates ERRα or ERRγ to activate SF-1 promoter activity, implying that ERRs may mediate PGC-1α action on SF-1 gene expression. However, we cannot rule out the possibility that other factors also mediate PGC-1α action on SF-1 gene expression. Further studies are required to determine whether ERRs binds to the SF-1 gene promoter and act as direct transcription factors for SF-1.
When our present manuscript was in preparation, Yazawa et al. [45] defined the role of PGC-1α in the differentiation of UCB (umbilical cord)-derived MSCs (mesenchymal stem cells) and demonstrated that PGC-1α regulates progesterone production in granulose cells through SF-1 and LRH-1 (liver receptor homologue 1). In the present study, we showed that PGC-1α regulates LH and ALD production in αT3-1 cells and Y-1 cells respectively through SF-1 and we provided more convincing evidence to demonstrate that PGC-1α interacts with SF-1 in vivo and in vitro, including promoter-luciferase reporter gene assays, mammalian two-hybrid, co-immunoprecipitation and ChIP assays and GST pull-down experiments. We also demonstrated that SF-1 mediates PGC-1α regulation of LH and ALD production in αT3-1 cells and Y-1 cells respectively by SF-1-knockdown experiments.
In summary, in the present study, we have shown that PGC-1α can interact with and co-activate SF-1 to induce LHβ and αGSU gene expression, leading to increased secretion of LH in pituitary gonadotrope-derived αT3-1 cells. PGC-1α also stimulates Cyp11b2 expression and ALD synthesis in adrenalcortex-derived Y-1 cells. SF-1 is a key regulator of endocrine function within the hypothalamic-pituitary-gonadal reproductive axis and adrenal cortex. It is reasonable to propose that PGC-1α may play important roles in steroidogenesis, gonad development and sex differentiation in these tissues through its interaction with and co-activation of SF-1. 
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